NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine?

Int J Cardiol. 2008 Jul 4;127(2):290-1. doi: 10.1016/j.ijcard.2007.04.048. Epub 2007 Jun 13.

Abstract

The aim of the study was to assess whether NGAL and cystatin C could predict contrast-induced nephropathy in non-diabetic patients (n=60, mean age 60+/-11 years) with normal serum creatinine undergoing elective PCI. We found a significant rise in serum NGAL after 2, 4 and 8 h, and in urinary NGAL after 4, 8 and 24 h after PCI. Cystatin C rose significantly 8 and 24 h after the procedure. Prevalence of CIN was 10%. We found 90% sensitivity and 74% specificity of serum and 76% sensitivity and 80% specificity of urinary NGAL increase. NGAL may represent a sensitive early biomarkers of renal impairment after PCI.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / blood
  • Acute Kidney Injury / chemically induced*
  • Acute Kidney Injury / urine
  • Acute-Phase Proteins
  • Analysis of Variance
  • Angina Pectoris / therapy*
  • Angioplasty, Balloon, Coronary
  • Biomarkers / blood
  • Biomarkers / urine
  • Contrast Media / adverse effects*
  • Creatinine / blood
  • Cystatin C
  • Cystatins / blood*
  • Cystatins / urine*
  • Female
  • Humans
  • Kidney Function Tests
  • Lipocalin-2
  • Lipocalins / blood*
  • Lipocalins / urine*
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Proto-Oncogene Proteins
  • Sensitivity and Specificity

Substances

  • Acute-Phase Proteins
  • Biomarkers
  • CST3 protein, human
  • Contrast Media
  • Cystatin C
  • Cystatins
  • LCN2 protein, human
  • Lipocalin-2
  • Lipocalins
  • Proto-Oncogene Proteins
  • Creatinine